Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021
Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2022-09-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/1606 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850023112207237120 |
|---|---|
| author | E. I. Burtseva L. V. Kolobukhina O. L. Voronina A. V. Ignatjeva E. A. Mukasheva A. D. Panova E. L. Feodoritova K. G. Krasnoslodotsev S. V. Trushakova L. N. Merkulova I. N. Khlopova N. V. Breslav N. N. Ryzhova M. S. Kunda E. I. Aksenova R. V. Vartanyan L. B. Kisteneva O. A. Burgasova A. G. Rosatkevich I. S. Kruzhkova M. V. Bazarova S. V. Smetanina N. A. Tsvetkova Yu. S. Levochkina M. V. Kozlova D. O. Korostin E. I. Botsmanov |
| author_facet | E. I. Burtseva L. V. Kolobukhina O. L. Voronina A. V. Ignatjeva E. A. Mukasheva A. D. Panova E. L. Feodoritova K. G. Krasnoslodotsev S. V. Trushakova L. N. Merkulova I. N. Khlopova N. V. Breslav N. N. Ryzhova M. S. Kunda E. I. Aksenova R. V. Vartanyan L. B. Kisteneva O. A. Burgasova A. G. Rosatkevich I. S. Kruzhkova M. V. Bazarova S. V. Smetanina N. A. Tsvetkova Yu. S. Levochkina M. V. Kozlova D. O. Korostin E. I. Botsmanov |
| author_sort | E. I. Burtseva |
| collection | DOAJ |
| description | Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article uses methods used in epidemiological surveillance of acute respiratory viral infections. Results and discussion. The results of the diagnostic available ARVI pathogens monitoring during epidemic seasons 2018-2021 are presented. The tendency of greater engagement of aged group 15 y.o. and older in epidemic process by morbidity and hospitalization due to SARI was shown. 49 818 nasal swabs from patients with influenza infection, 36 044 – with ARVI and 59 062 – with SARS-CoV-2 were tested. The top three in the structure of ARVI were INF, HEV-D and HRSV (in the 2018–2019 season); INF, SARS-CoV-2 and HEV-D (2019–2020); SARS-CoV-2, HEV-D and HPIV/HCoV (2020–2021). The activity of viral pathogens also differed: for HPIV, HAdV, HEV-D, HMPV, a decrease in activity was noted during the appearance of SARS-CoV-2 (2019–2020) and some of its growth in the following season; in relation to HRSV and INF - a decrease in activity during the last two seasons, and for INF – extremely low activity in the 2020-2021 season; the activity of seasonal HCoV even increased slightly. The data of genetic analyses of SARS-CoV-2 positive samples showed the heterogeneity of its population with a representative of variants (Alfa, Delta) as well as endemic for Russia and Moscow variants only. The recommended composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season and in the 2022 southern hemisphere influenza season are presented due to their drift changeability. Conclusions. SARS-CoV-2 was influenced by the activity of ARVI pathogens with the almost complete displacement of influenza viruses from the circulation in the period 2020–2021. |
| format | Article |
| id | doaj-art-2ad3ac4edaf3443f95f43f0c880cc93c |
| institution | DOAJ |
| issn | 2073-3046 2619-0494 |
| language | Russian |
| publishDate | 2022-09-01 |
| publisher | Numikom LLC |
| record_format | Article |
| series | Эпидемиология и вакцинопрофилактика |
| spelling | doaj-art-2ad3ac4edaf3443f95f43f0c880cc93c2025-08-20T03:01:28ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942022-09-01214162610.31631/2073-3046-2022-21-4-16-26854Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021E. I. Burtseva0L. V. Kolobukhina1O. L. Voronina2A. V. Ignatjeva3E. A. Mukasheva4A. D. Panova5E. L. Feodoritova6K. G. Krasnoslodotsev7S. V. Trushakova8L. N. Merkulova9I. N. Khlopova10N. V. Breslav11N. N. Ryzhova12M. S. Kunda13E. I. Aksenova14R. V. Vartanyan15L. B. Kisteneva16O. A. Burgasova17A. G. Rosatkevich18I. S. Kruzhkova19M. V. Bazarova20S. V. Smetanina21N. A. Tsvetkova22Yu. S. Levochkina23M. V. Kozlova24D. O. Korostin25E. I. Botsmanov26FSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of HealthClinical Hospital for Infectious Diseases № 1 Department of Health of MoscowClinical Hospital for Infectious Diseases № 1 Department of Health of MoscowClinical Hospital for Infectious Diseases № 2 Department of Health of MoscowFSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of Health; Clinical Hospital for Infectious Diseases № 2 Department of Health of MoscowClinical Hospital for Infectious Diseases № 2 Department of Health of MoscowCenter for High-Precision Editing and Genetic Technologies for Biomedicine of the N.I. Pirogov Federal State Medical University of the Ministry of Health of RussiaCenter for High-Precision Editing and Genetic Technologies for Biomedicine of the N.I. Pirogov Federal State Medical University of the Ministry of Health of RussiaRelevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article uses methods used in epidemiological surveillance of acute respiratory viral infections. Results and discussion. The results of the diagnostic available ARVI pathogens monitoring during epidemic seasons 2018-2021 are presented. The tendency of greater engagement of aged group 15 y.o. and older in epidemic process by morbidity and hospitalization due to SARI was shown. 49 818 nasal swabs from patients with influenza infection, 36 044 – with ARVI and 59 062 – with SARS-CoV-2 were tested. The top three in the structure of ARVI were INF, HEV-D and HRSV (in the 2018–2019 season); INF, SARS-CoV-2 and HEV-D (2019–2020); SARS-CoV-2, HEV-D and HPIV/HCoV (2020–2021). The activity of viral pathogens also differed: for HPIV, HAdV, HEV-D, HMPV, a decrease in activity was noted during the appearance of SARS-CoV-2 (2019–2020) and some of its growth in the following season; in relation to HRSV and INF - a decrease in activity during the last two seasons, and for INF – extremely low activity in the 2020-2021 season; the activity of seasonal HCoV even increased slightly. The data of genetic analyses of SARS-CoV-2 positive samples showed the heterogeneity of its population with a representative of variants (Alfa, Delta) as well as endemic for Russia and Moscow variants only. The recommended composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season and in the 2022 southern hemisphere influenza season are presented due to their drift changeability. Conclusions. SARS-CoV-2 was influenced by the activity of ARVI pathogens with the almost complete displacement of influenza viruses from the circulation in the period 2020–2021.https://www.epidemvac.ru/jour/article/view/1606arviinfluenzasars-cov-2epidemic seasons 2018–2021molecular and genetic properties |
| spellingShingle | E. I. Burtseva L. V. Kolobukhina O. L. Voronina A. V. Ignatjeva E. A. Mukasheva A. D. Panova E. L. Feodoritova K. G. Krasnoslodotsev S. V. Trushakova L. N. Merkulova I. N. Khlopova N. V. Breslav N. N. Ryzhova M. S. Kunda E. I. Aksenova R. V. Vartanyan L. B. Kisteneva O. A. Burgasova A. G. Rosatkevich I. S. Kruzhkova M. V. Bazarova S. V. Smetanina N. A. Tsvetkova Yu. S. Levochkina M. V. Kozlova D. O. Korostin E. I. Botsmanov Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 Эпидемиология и вакцинопрофилактика arvi influenza sars-cov-2 epidemic seasons 2018–2021 molecular and genetic properties |
| title | Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 |
| title_full | Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 |
| title_fullStr | Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 |
| title_full_unstemmed | Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 |
| title_short | Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021 |
| title_sort | features of the circulation of arvi pathogens during of emergence and widespread of sars cov 2 in the 2018 2021 |
| topic | arvi influenza sars-cov-2 epidemic seasons 2018–2021 molecular and genetic properties |
| url | https://www.epidemvac.ru/jour/article/view/1606 |
| work_keys_str_mv | AT eiburtseva featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT lvkolobukhina featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT olvoronina featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT avignatjeva featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT eamukasheva featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT adpanova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT elfeodoritova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT kgkrasnoslodotsev featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT svtrushakova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT lnmerkulova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT inkhlopova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT nvbreslav featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT nnryzhova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT mskunda featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT eiaksenova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT rvvartanyan featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT lbkisteneva featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT oaburgasova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT agrosatkevich featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT iskruzhkova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT mvbazarova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT svsmetanina featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT natsvetkova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT yuslevochkina featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT mvkozlova featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT dokorostin featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 AT eibotsmanov featuresofthecirculationofarvipathogensduringofemergenceandwidespreadofsarscov2inthe20182021 |